Greif's CEO, Ole Rosgaard, sees the acquisition as a crucial step in their Build to Last strategy, unlocking new capabilities and market opportunities. The company aims to drive benefits, support growth, and capture $7 million of synergies through Ipackchem's integration.
Insider selling of shares, particularly below current price, is seen as negative, implying a lower price is reasonable. High insider ownership in Greif may suggest management's consideration for shareholder interests. The absence of insider transactions in the past three months is not confidence-inspiring.
The low P/E ratio of Greif, Inc. might be due to expected EPS slump. Investors may not see earnings improvement potential to justify a higher P/E ratio, possibly limiting future share price growth.
High debt carried by the company raises concerns given the substantial reliance on borrowed funds. When considering ROE, other indicators such as profit growth rates and stock pricing must also be evaluated.
Insider transactions indicate mixed sentiment: high level of insider ownership may imply alignment with shareholder interests. However, the share sales, particularly below current prices, may signal lack of confidence in future prospects.
Gainers: •$西格內特珠寶(SIG.US)$+7.6% (In reaction to earnings/guidance) •$牛津工業(OXM.US)$+6.3% (In reaction to earnings/guidance) •$BridgeBio Pharma(BBIO.US)$+5%(to Present Phase 2b Data and Pivotal Phase 3 Study Design of Encaleret in Autosomal Dominant Hypocalcemia Type 1 (ADH1) at the Endocrine Society (ENDO) 2022 Annual Conference) •$格瑞夫(GEF.US)$+4.6% (In reaction to earnings/guidance) •$Olema Pharmaceuticals(OLMA.US)$+4.3% (an...
Upgrades •$Boot Barn Holdings(BOOT.US)$: Baird Upgrades to Outperform from Neutral - PT $115 •$波士頓科學(BSX.US)$: Needham Upgrades to Buy from Hold - PT $48 •$Graphic Packaging(GPK.US)$: BMO Capital Upgrades to Outperform from Market Perform - PT $25 (from $20) •$HCA醫療(HCA.US)$: Bernstein Upgrades to Outperform from Market Perform - PT $271 •$愛奇藝(IQ.US)$: Citigroup Upgrades to Buy from Neutral - PT $5 (from $4.50) •$梅西百貨(M.US)$: Morgan ...
格瑞夫股票討論區
$凌雲半導體(CRUS.US)$ $綠色平原能源(GPRE.US)$ $海天網絡(HKIT.US)$ $格瑞夫(GEF.US)$
📊⚡️📊
• $西格內特珠寶(SIG.US)$ +7.6% (In reaction to earnings/guidance)
• $牛津工業(OXM.US)$ +6.3% (In reaction to earnings/guidance)
• $BridgeBio Pharma(BBIO.US)$ +5%(to Present Phase 2b Data and Pivotal Phase 3 Study Design of Encaleret in Autosomal Dominant Hypocalcemia Type 1 (ADH1) at the Endocrine Society (ENDO) 2022 Annual Conference)
• $格瑞夫(GEF.US)$ +4.6% (In reaction to earnings/guidance)
• $Olema Pharmaceuticals(OLMA.US)$ +4.3% (an...
• $紅羅賓(RRGB.US)$ +13.8% (In reaction to earnings)
• $PMV Pharmaceuticals(PMVP.US)$ +11.2% (ASCO-related announcement)
• $Sumo Logic(SUMO.US)$ +10.8% (In reaction to earnings)
• $艾切托(ACET.US)$ +9.6% (ASCO-related announcement)
• $戴爾科技(DELL.US)$ +9.6% (In reaction to earnings)
• $ImmunoGen(IMGN.US)$ +8.7% (ASCO-related announcement)
• $Ulta美容(ULTA.US)$ +7.9% (In reaction to earnings)
• $Zymergen(ZY.US)$ +7.8% (to...
• $Boot Barn Holdings(BOOT.US)$ : Baird Upgrades to Outperform from Neutral - PT $115
• $波士頓科學(BSX.US)$ : Needham Upgrades to Buy from Hold - PT $48
• $Graphic Packaging(GPK.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $25 (from $20)
• $HCA醫療(HCA.US)$ : Bernstein Upgrades to Outperform from Market Perform - PT $271
• $愛奇藝(IQ.US)$ : Citigroup Upgrades to Buy from Neutral - PT $5 (from $4.50)
• $梅西百貨(M.US)$ : Morgan ...
暫無評論